Suicide research remains fraught with ethical and methodological issues, including researchers' reservations about conducting intensive suicide research protocols due to potential iatrogenic effects and liability concerns. Such issues significantly impede scientific inquiry related to suicide. To date, no research has explored potential iatrogenic effects of intensive, nontreatment suicide research among Veterans. This study aimed to fill this gap. It was hypothesized that participation in suicide-specific protocols would not significantly increase risk among Veterans. Veterans completed self-reports, structured interviews, and rigorous suicide-specific tasks (Study A, N = 34; Study B, N = 18; Study C, N = 119). Findings indicated there were no significant differences in pre-and postassessment suicide risk variables (all ps > .05). Estimated mean change for "urge to harm self" was À0.24 (95% confidence interval [CI]: À0.60, 0.13), À0.28 (CI: À0.56, 0.01), and À0.01 (CI: À0.09, 0.07) and "intent to harm self" was À0.18 (95% CI: À0.45, 0.10), 0 (CI: À0.17, 0.17), and 0.01 (CI: À0.04, 0.06) for Studies A, B, and C, respectively. Results indicated the respective protocols did not produce iatrogenic effects. The current findings are discussed with attention to safety-monitoring techniques that may reduce iatrogenic effects and considerations for future researchers.
Suicide research remains fraught with ethical and methodological issues, including researchers' reservations about conducting intensive suicide research protocols due to potential iatrogenic effects and liability concerns. Such issues significantly impede scientific inquiry related to suicide. To date, no research has explored potential iatrogenic effects of intensive, nontreatment suicide research among Veterans. This study aimed to fill this gap. It was hypothesized that participation in suicide-specific protocols would not significantly increase risk among Veterans. Veterans completed self-reports, structured interviews, and rigorous suicide-specific tasks (Study A, N = 34; Study B, N = 18; Study C, N = 119). Findings indicated there were no significant differences in pre-and postassessment suicide risk variables (all ps > .05). Estimated mean change for "urge to harm self" was À0.24 (95% confidence interval [CI] : À0.60, 0.13), À0.28 (CI: À0.56, 0.01), and À0.01 (CI: À0.09, 0.07) and "intent to harm self" was À0.18 (95% CI: À0.45, 0.10), 0 (CI: À0.17, 0.17), and 0.01 (CI: À0.04, 0.06) for Studies A, B, and C, respectively. Results indicated the respective protocols did not produce iatrogenic effects. The current findings are discussed with attention to safety-monitoring techniques that may reduce iatrogenic effects and considerations for future researchers.
Suicide has remained a leading cause of death in the United States for decades with little to no observed success in reducing overall suicide rates despite increased attention (Center for Disease Control and Prevention, 2017; McKeown, Cuffe, & Schulz, 2006) . Further, Veteran suicide rates have increased over the last decade (Office of Suicide Prevention [OSP], 2016) . These data indicate that additional research must be carried out to better understand suicide risk to improve intervention efforts. Despite this, there remains a tendency across disciplines to exclude individuals at risk of suicide and/or to omit suicide-specific variables. Such reticence to conduct suicide-related research impedes scientific inquiry, thereby obfuscating meaningful and effective progress. Common barriers associated with conducting suicide research often include liability concerns, perception of increased researcher stress when evaluating suicide risk, concerns that suicide inquiry will elevate risk, internal validity concerns if protocol deviations occur to manage suicide risk, and/or systemic barriers (institutional review board concerns, lengthy approval processes from multiple agencies, e.g., Lakemen & Fitzgerald, 2009a; Lakeman & Fitzgerald, 2009b) . Given this, the current study sought to allay some of these concerns by empirically demonstrating that such studies can be conducted safely among Veterans.
Previous research with civilians suggests that participating in non-treatmentrelated suicide research does not produce significant iatrogenic effects (e.g., Cha et al., 2016; Gould et al., 2005) . For example, Smith, Poindexter, and Cukrowicz (2010) conducted a study investigating psychiatric and suicide-specific symptoms and physiological reactivity when exposed to an affectively modulated startle reflex task. Results indicated that study participation did not increase suicide risk at 1-and 3-month follow-ups. The impact of suicidespecific research, however, has not been examined among Veterans seeking care at the Veterans Health Administration, a population at elevated suicide risk (OSP, 2016) . Further, no studies have examined such considerations across different methodological approaches among Veterans.
In this study we examined whether nontreatment research protocols with specific, comprehensive, and time-intensive inquiry about suicide and related risk factors increased risk for participant harm among Veterans across three studies with three different designs (nonexperimental, quasiexperimental, and experimental) . For all studies, it was hypothesized that participation in suicide-specific protocols would not significantly increase risk.
METHOD
The university institutional review board and Veterans Affairs Medical Center (VAMC) Research and Development Committee approved each study. Veterans were sampled from a VAMC in the Rocky Mountain Region, and all provided written informed consent. Complete demographic, military, suicide ideation, and attempt history are provided in Table 1 . The methods of the studies varied, but all included suicide and psychiatric self-report and structured interview assessments with rigorous suicidespecific tasks that included exposure to suicide-specific thoughts, images, and/or mood induction. A description of study methods is provided in Table 2 . The University of Washington Risk Assessment ProtocolRevised (UWRAP; Linehan, Comtois, & Murray, 2000) , recommended by the National Institute of Mental Health and utilized in over 20 years of suicide research, was used to assess and monitor potential risks associated with participation in each study (administered at the beginning and end of the research session). This measure offered a systematic approach to assess and intervene if iatrogenic effects were endorsed on postassessment. Scores ranged from 1 to 7, with higher scores indicating greater distress. Two questions from the UWRAP were used to determine the iatrogenic effect of study participation: (1) urge to harm yourself now [Urge] and (2) intent to kill yourself right now [Intent] . For all studies, a score of five or greater on the UWRAP items would have resulted in further risk evaluation from a designated clinician. Additionally, all participants were instructed to contact the research team if delayed negative experiences occurred due to research participation (i.e., adverse events).
EFFECTS OF SUICIDE RESEARCH WITH VETERANS

RESULTS
Secondary data analyses included paired t tests (Studies A and C) and Wilcoxon signed rank tests (Study B) to compare preand post-UWRAP scores. All analyses were run in SAS 9.4 (SAS Institute Inc., Cary, NC, USA). Results indicated that there was no significant difference between pre-and post-UWRAP scores on the "Urge" or "Intent" questions, across all studies (all ps > .05). Negative scores indicate lower postassessment ratings. For the "Urge" question, the estimated mean change was À0.24 (95% confidence interval [CI]: À0.60, 0.13), À0.28 (CI: À0.56, 0.01), and À0.01 (CI: À0.09, 0.07) for Studies A, B, and C, respectively. For the "Intent" question, the estimated mean change was À0.18 (95% CI: À0.45, 0.10), 0 (CI: À0.17, 0.17), and 0.008 (CI: À0.04, 0.06) for Studies A, B, and C, respectively. Most responses on the UWRAP remained unchanged or decreased from preto postassessment. No participant scored above a five on the UWRAP at postassessment, indicating that no participant required supplemental assessment or intervention. See Table 3 for UWRAP score distribution. No adverse events were reported during or after participation.
DISCUSSION
This is the first study to evaluate the potential for iatrogenic effects resulting from comprehensive assessments of psychopathology and suicide risk during nontreatment research among Veterans. Across three intensive suicide research studies, Note. To characterize past-month suicide ideation and lifetime suicide attempts, the ColumbiaSuicide Severity Rating Scale (Posner et al., 2011) was administered in Studies B and C. Suicide attempt history was characterized with the Suicide Attempt Self-Injury Interview (Linehan, Comtois, Brown, Heard, & Wagner, 2006) in Study A. To meet inclusion for all studies, Veterans must have been eligible to receive care at the facility, be English speaking, and be able to provide informed consent.
b Nazem, Forster, and Brenner (2017) include a more extensive description of Study C's methodological approach.
results indicated that participants did not endorse significant increases in suicide risk at postassessment or report adverse events. Collectively, the results add to a body of research demonstrating the feasibility of conducting intensive, nontreatment suicidespecific research without doing harm to participants (e.g., Cha et al., 2016; Smith et al., 2010) . Given this, the aforementioned barriers to suicide research (e.g., liability concerns, risk management) should not inherently thwart suicide research or provide the basis for indiscriminately excluding participants at risk of suicide from research. This is further highlighted by ethical principles that dictate that "individuals should not be excluded from the opportunity to participate in research without a good scientific reason or susceptibility to risk that justifies their exclusion" (i.e., fair subject selection; cf., Emanuel, Wendler, & Grady, 2000 , p. 2704 . Instead, governing agencies and researchers should use empirical evidence and ethical principles to guide decision making and scientific procedures. Future research, across disciplines, should be able to reasonably incorporate suicide-specific variables when extant empirical literature guides methodological design, good ethical decision making is exercised (e.g., favorable risk-benefit ratio), and safety-monitoring techniques are appropriately considered and implemented (e.g., standardized safety-monitoring procedures such as the UWRAP).
The presented studies are not without limitations. Two of the three samples were relatively small and may limit the generalizability of the findings. Further, the study designs did not employ a longitudinal followup to evaluate postprotocol iatrogenic effects. However, it is unlikely that lasting significant iatrogenic effects occurred given the lack of acute changes on the UWRAP and that no adverse events were reported to study teams. Future research that more robustly evaluates the effects of suicide research will require large longitudinal samples capable of establishing baseline functioning because high-risk populations will continue to experience UWRAP, University of Washington Risk Assessment Protocol-Revised. a The UWRAP is measured using a 7-point Likert scale ranging from 1 (low) to 7 (high). Ordinal change from pre-to postassessment reflects the ordinal change that a participant reported at postassessment on the UWRAP.
b All studies used the recommended UWRAP cutoff of 5 or greater to initiate a further risk evaluation and/or appropriate clinical procedures. No participant, at postassessment, endorsed a score of 5 or higher on the UWRAP. Thus, any reported increase in UWRAP scores did not result in a risk level significant enough to warrant additional assessment or intervention.
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EFFECTS OF SUICIDE RESEARCH WITH VETERANS negative health outcomes (e.g., suicidal behavior) independent of research participation. Despite these limitations, the current results provide valuable Veteran-specific data to support the safety of intensive suicide-specific research across distinct methodological approaches. Further, structured safety-monitoring assessments, such as the UWRAP, will likely help address many of the barriers discussed previously (e.g., researcher anxiety, standardization procedures; Linehan, Comtois, & Ward-Ciesielski, 2012) . Thus, the current findings, coupled with the extant research, should help inform researchers and governing/ethical agencies on how to better implement and evaluate suicide-specific methodological approaches to help advance suicide research and ultimately save lives.
